教室紹介

2014年業績集

受賞

  1. 第21回日本泌尿器科学会賞

    松岡　陽．
    Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy.

  2. 米国泌尿器科学会 "Outstanding Poster Presentation"

    Fukushima H, Yoshida S, Koga F, Nakanishi Y, Kijima T, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K. Reduced TRAP1 expression is associated with poor prognosis in upper urinary tract urothelial carcinoma patients: its implications for tumor invasion.
    "Outstanding Poster Presentation" The 108th annual meeting of the American Urological Association, Orlando, USA. 2014/5/18

  3. 第102回日本泌尿器科学会総会 総会賞

    石岡淳一郎, 木原和徳, 竹下英毅, 中西泰一, 木島敏樹, 吉田宗一郎, 松岡　陽, 沼尾　昇, 齋藤一隆, 藤井靖久. ヘッドマウントディスプレイシステムの尿路上皮癌内視鏡検査/手術への応用. 第102回日本泌尿器科学会総会 2014年4月24日

  4. 第102回日本泌尿器科学会総会 総会賞

    田中 一、吉田 宗一郎、林 達郎、砂倉 瑞明、浦上 慎司、湯浅 健、山本 真也、増田 均、福井 巌、米瀬 淳二、藤井 靖久、木原 和徳. 腎盂尿管癌の転移巣診断における18F-FDG PET/CTの有用性に関する検討. 第102回日本泌尿器科学会総会 2014年4月24日

  5. 第10回泌尿器腫瘍放射線研究会 優秀演題賞

    福島啓司、古賀文隆、横山みなと、中西泰一、鳶巣賢一．進行性尿路上皮癌のバイオマーカーとしてのサルコペニアの意義．"優秀演題賞"　第10回泌尿器腫瘍放射線(GUTR)研究会、横浜、2014年8月30日

学会発表

欧州泌尿器科学会（European Association of Urology annual congress）

  1. Inoue M, Koga F, Yoshida S, Kijima T, Nakanishi Y, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K. ErbB2 overexpression predicts chemoradiotherapy resistance and worse prognosis in muscle-invasive bladder cancer patients treated with induction chemoradiotherapy followed by partial or radical cystectomy The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/13

  2. Inoue M, Numao N, Ito M, Takeshita H, Kijima T, Nakanishi Y, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Impact of androgen deprivation therapy on cardiovascular disease in patients with non-metastatic high-risk prostate cancer The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/14

  3. Ishikawa Y, Numao N, Ishii C, Kijima T, Nakanishi Y, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Potential of prebiopsy MRI to reduce biopsies in men with suspected clinically localized prostate cancers in the repeat biopsy setting The 29th Annual Congress of the European Association of Urology Stockholm, Sweden, 2014/4/14

  4. Ishioka J, Kihara K, Fujii Y, Saito K, Masuda H, Koga F. Numao N, Matsuoka Y, Yoshida S, Takeshita H, Higuchi S, Nakayama T. New head-mounted display system applied to endoscopic management off urothelial cancers The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2013/4/14

  5. Kihara K, Fujii Y, Saito K, Masuda H, Koga F, Numao N, Ishioka J, Matsuoka Y, New 3-dimensional head-mounted display system (RoboSurgeon System) applied to gasless, two-port access total nephroureterectomy. "Highlights and awards section" The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/13

  6. Koga F., Inoue M., Kijima T., Yoshida S., Ishioka J., Matsuoka Y., Numao N., Saito K., Masuda H., Fujii Y., Kihara K. Pre-therapeutic risk stratification of muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/13

  7. Matsuoka Y, Numao N, Saito K, Tanaka H, Kijima T, Nakanishi Y, Yoshida S, Ishioka J, Fujii Y, Kihara K. Topographical risk stratification of undertreatment in focal therapy for prostate cancer: Mid-apical biopsy compensates for MRI underdiagnosis. The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/13

  8. Numao N, Matsuoka Y, Ito M, Yoshida S, Ishikawa Y. Uchida Y, Toide M, Higuchi S, Nakayama T, Inoue M, Takeshita H, Kijima T, Nakanishi Y, Ishioka J, Saito K, Fujii Y, Kihara K Direct comparison of the ability to detect significant prostate cancer and assess cancer characteristics between magnetic resonance imaging targeted biopsy and systematic 14-core biopsy, including anterior samplings The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/14

  9. Takeshita H, Kihara K, Masuda H, Koga F, Nakanishi Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y. Favourable quality of life and urinary functions after bladder preservation in muscle-invasive bladder cancer patients treated with induction chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection. The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/12

  10. Yoshida S, Kihara K, Takeshita T, Inoue M, Nakanishi Y, Kijima T, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y Head-mounted display-based personal integrated-image monitoring system for TURP The 29th Annual Congress of the European Association of Urology, Stockholm, Sweden, 2014/4/13

米国泌尿器科学会（annual meeting of the American Urological Association）

  1. Fukushima H, Yokoyama M, Koga F Sarcopenia is a prognostic biomarker of advanced urothelial carcinoma. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/19

  2. Fukushima H, Yoshida S, Koga F, Nakanishi Y, Kijima T, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K Reduced TRAP1 expression is associated with poor prognosis in upper urinary tract urothelial carcinoma patients: its implications for tumor invasion. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/18

  3. Higuchi S, Kijima T, Nakanishi Y, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K. Antimicrobial prophylaxis is avoidable in minimally invasive nephroureterectomy with negative urine culture. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/17

  4. Inoue M, Koga F, Yoshida S, Kijima T, Nakanishi Y, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K. ErbB2 overexpression is relevant to therapeutic resistance and poor prognosis in muscle-invasive bladder cancer patients treated with chemoradiation-based bladder-sparing protocol. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/18

  5. Ishikawa Y, Numao N, Ishii C, Kijima T, Nakanishi Y, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Identification of patients who can avoid repeat biopsy using multiparametric magnetic resonance imaging. The 108th annual meeting of the American Urological Association Orlando, USA, 2014/5/20

  6. Ito M, Numao N, Nakanishi Y, Kijima T, Yoshida S, Ishioka J, Mastuoka Y, Saito K, Fujii Y, Kihara K. Biopsy Gleason score 3+4 may be included as criteria for active surveillance after 2005 International Society of Urological Pathology consensus. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/20

  7. Kijima T, Kihara K, Fujii Y, Koga F, Nakanishi Y, Yoshida S, Ishioka J, Matsuoka Y, Numao N, Saito K, Masuda H. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy and consolidative partial cystectomy in muscle invasive bladder cancer patients with synchronous or metachronous multifocality. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/19

  8. Kihara K, Saito K, Nakanishi Y, Kijima T, Yoshida S, Ishioka J, Mastuoka Y, Numao N, Koga F, Masuda H, Fujii Y. Favorable outcomes of gasless single-port clampless partial nephrectomy using new three dimensional head-mounted display system (RoboSurgeon system). The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/17

  9. Numao N, Matsuoka Y, Ito M, Yoshida S, Ishikawa Y. Uchida Y, Toide M, Higuchi S, Nakayama T, Inoue M, Takeshita H, Kijima T, Nakanishi Y, Ishioka J, Saito K, Fujii Y, Kihara K Potential of additional magnetic resonance imaging (MRI)-targeted prostate biopsy to avoid underestimation of systematic 14-core biopsy. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/18

  10. Tanaka H, Yoshida S, Komai Y, Hayashi T, Sakura M, Urakami S, Sakai Y, Yuasa T, Yamamoto S, Masuda H, Fukui I, Yonese J, Fujii Y, Kihara K The value of 18F-FDG PET/CT in staging of upper tract urothelial carcinoma: impact on patient management. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/16

  11. Yoshida S, Koga F, Tanaka H, Satoh S, Nakanishi Y, Kijima T, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, Kihara K Diffusion-weighted MRI for assessing the response of muscle-invasive bladder cancer to chemoradiotherapy. The 108th annual meeting of the American Urological Association, Orlando, USA, 2014/5/17

原著

  1. Matsuoka Y, Numao N, Saito K, Tanaka H, Kumagai J, Yoshida S, Koga F, Masuda H, Kawakami S, Fujii Y, Kihara K. Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. Eur Urol, 65: 186-92, 2014.PubMed

  2. Matsuoka Y, Kihara K, Kawashima K, Fujii Y. Integrated image-navigation system using head-mounted display in "RoboSurgeon" endoscopic radical prostatectomy. Wideochir Inne Tech Malo Inwazyjne, 9(4): 613-618, 2014

  3. Matsuoka Y, Numao N, Saito K, Tanaka H, Kumagai J, Yoshida S, Ishioka J, Koga F, Masuda H, Kawakami S, Fujii Y, Kihara K. Candidate selection for quadrant-based focal ablation through a combination of diffusion-weighted magnetic resonance imaging and prostate biopsy. BJU International, In press.

  4. Jibiki M, Inoue Y, Kudo T, Toyofuku T, Saito K, Kihara K, Kudo A, Ban D, Arii S. Combined resection of a tumor and the inferior vena cava: report of twocases. Surg Today. 44: 166-70, 2014. PubMed